Orthofix to Report Second Quarter 2024 Financial Results
Orthofix Medical (NASDAQ: OFIX) will release its second quarter 2024 financial results on August 6, 2024, before the market opens. The company will host a conference call and webcast at 8:30 am ET on the same day to discuss the results.
Participants in the U.S. can join the call by dialing (888) 330-2508, and international participants can dial (240) 789-2735, using the passcode 9556380. A replay will be available for three weeks at (800) 770-2030 in the U.S. and (647) 362-9199 internationally, with the same passcode.
Investors can access the webcast and press release at ir.Orthofix.com. Orthofix regularly updates important information on its Investor Relations page.
- None.
- None.
Company to Host Conference Call on Tuesday, August 6, 2024 at 8:30 am ET
Interested parties may access the conference call by dialing (888) 330-2508 in the
Internet Posting of Information
Orthofix routinely posts information that may be important to investors in the “Investor Relations” section of its website at www.orthofix.com. The Company encourages investors and potential investors to consult the Orthofix website regularly for important information about Orthofix.
About Orthofix
Orthofix is a leading global spine and orthopedics company with a comprehensive portfolio of biologics, innovative spinal hardware, bone growth therapies, specialized orthopedic solutions, and a leading surgical navigation system. Its products are distributed in more than 60 countries worldwide. The Company is headquartered in
View source version on businesswire.com: https://www.businesswire.com/news/home/20240709865604/en/
Investor Relations
Julie Dewey
JulieDewey@Orthofix.com
209.613.6945
Media Relations
Denise Landry
DeniseLandry@Orthofix.com
214.937.2529
Source: Orthofix Medical Inc.
FAQ
When will Orthofix release its Q2 2024 financial results?
What is the date and time for Orthofix's Q2 2024 earnings conference call?
How can investors access Orthofix's Q2 2024 financial results conference call?
Where can investors find a replay of Orthofix's Q2 2024 earnings call?